Status:
RECRUITING
Effects of Sufentanil on the Intraoperative Hemodynamics
Lead Sponsor:
Seoul National University Hospital
Conditions:
Intraoperative Hypotension
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
This study is a randomized, controlled trial. A total of 92 patients will be randomized to receive sufentanil or remifentanil during extracranial-intracranial bypass surgery.
Eligibility Criteria
Inclusion
- Patients who undergo elective extracranial-intracranial bypass surgery
- American Society of Anesthesiologists grade 1,2,3
- Age \> 18 years old
Exclusion
- Refuse to participate to the study
- American Society of Anesthesiologists grade 4
- Body Mass Index \< 18.5 kg/m2 or \> 35 kg/m2
- Allergic history of opioid
- pregnant
- MAO Inhibitor user
- Severe respiratory insufficiency
Key Trial Info
Start Date :
November 24 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT06091904
Start Date
November 24 2023
End Date
November 1 2026
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 13620